Switch
Homepage
facebook
IG
Other Hospital
CMUH App
Department Introduction
Rheumatology and Immunology | Our Speciality
:::
Our Speciality
Management of Refractory Autoinflammatory Diseases (Primarily Adult-Onset Still’s Disease/AOSD)
▪ Provides a comprehensive one-stop medical service for AOSD.
▪ SNQ National Quality Certification (2022-2024).
▪ 35 SCI-indexed publications—the highest number of single-center publications globally.
▪ Research findings have been widely cited over 1,500 times and have received four patents (two from the United States and two from Taiwan).
Innovative allogeneic adipose-derived stem cell therapy for Connective Tissue Diseases with Interstitial Lung Disease (ILD)
▪ Conducting a Phase I/IIa clinical trial, which has been approved by Taiwan’s Ministry of Health and Welfare.
Personalized Screening and Prevention for Rheumatic Disease Comorbidities
▪ A patient-centered case management system with Risk Management Plans (RMPs), ensuring zero adverse events in the past 10 years.
▪ 20 SCI-indexed publications.
▪ Two patents (one in the United States and one in Taiwan).
▪ Developing the first Asia-Pacific guidelines for RA comorbidity prevention and management, cited 37 times in the past three years.
Facebook
IG
YouTube
▲